Federal award (DELIVERY ORDER, fiscal year 2023)
Recipient: DMS PHARMACEUTICAL GROUP INC
Awarding agency: Department of Defense / Defense Logistics Agency
Funding agency: Department of Defense / Defense Logistics Agency
Period of performance: 2024-01-29 to 2024-02-20
Current total value of award: $3573.45
Description: 4563651640!NEXPLANON 68 MG IMPLANTS